title: Reduced NM23 Protein Level Correlates With Worse Clinicopathologic Features in Colorectal Cancers: A Meta-Analysis of Pooled Data.
abstract: The clinical value of a prominent metastasis suppressor, nonmetastatic protein 23 (NM23), remains controversial. In this study, we examined the correlation between NM23 protein levels and the clinicopathologic features of colorectal cancers (CRC), and assessed the overall prognostic value of NM23 for CRC. Embase, PubMed, Web of Science, and other scientific literature databases were exhaustively searched to identify relevant studies published prior to June 31, 2015. The methodological qualities of selected studies were scored based on the critical appraisal skills program (CASP) criteria, as independently assessed by 2 reviewers. NM23 protein levels in tumor tissues of CRC patients were examined in relation to Dukes stage, differentiation grade, T-stage, lymph node metastasis status, and overall survival (OS). STATA software version 12.0 (Stata Corp, College Station, TX) was used for statistical analysis of data pooled from selected studies. Nineteen cohort studies met the inclusion criteria for present study and contained a combined total of 2148 study subjects. Pooled odd ratios (ORs) for NM23 expression revealed that reduced NM23 protein levels in CRC tumor tissues correlated with Dukes stage C and D (OR = 1.89, 95% CI: 1.06-3.39, P = 0.032), poor differentiation grades (OR = 1.41, 95% CI: 1.03-1.94, P = 0.032), and positive lymph node metastasis status (OR = 3.21, 95% CI: 1.95-5.29, P < 0.001). On the other hand, no such correlations were evident with T-stage T3-4 (OR = 1.56, 95% CI: 0.60-4.06, P = 0.367) or OS (OR = 0.79, 95% CI: 0.58-1.08, P = 0.138). Our analysis of pooled data found that NM23 expression is reduced in CRC tissues and low NM23 levels tightly correlate with higher Dukes stages, poorer differentiation grade, and positive lymph node metastases. However, NM23 levels did not influence the OS in CRC patients.
authors.affiliation: From the Department of Gastrointestinal Surgery, The First Affiliated Hospital, Shantou University Medical College, Shantou, China.
authors.forename: Tian
authors.initials: T
authors.lastname: Yang
authors.forename: Bo-Zan
authors.initials: BZ
authors.lastname: Chen
authors.forename: Dan-Feng
authors.initials: DF
authors.lastname: Li
authors.forename: Huai-Ming
authors.initials: HM
authors.lastname: Wang
authors.forename: Xiao-Sheng
authors.initials: XS
authors.lastname: Lin
authors.forename: Hong-Fa
authors.initials: HF
authors.lastname: Wei
authors.forename: Yong-Ming
authors.initials: YM
authors.lastname: Zeng
mesh_terms: D015179:Colorectal Neoplasms / Q000737:chemistry* / Q000473:pathology*; D006801:Humans; D008207:Lymphatic Metastasis; D054778:NM23 Nucleoside Diphosphate Kinases / Q000032:analysis*; D060787:Neoplasm Grading; D009367:Neoplasm Staging; D015996:Survival Rate
chemical_list: D054778:NM23 Nucleoside Diphosphate Kinases; C517942:NME3 protein, human
references.citation: Acta Clin Croat. 2012 Mar;51(1):43-9
references.pmid: 22920000
references.citation: Med Oncol. 2014 Jan;31(1):802
references.pmid: 24338217
references.citation: Zhonghua Yi Xue Za Zhi. 2009 May 26;89(20):1382-6
references.pmid: 19671326
references.citation: Br J Cancer. 2012 Apr 10;106(8):1374-8
references.pmid: 22421948
references.citation: Jpn J Clin Oncol. 2014 Jan;44(1):97-100
references.pmid: 24211857
references.citation: Oncol Rep. 1998 May-Jun;5(3):735-9
references.pmid: 9538187
references.citation: Arch Gynecol Obstet. 2013 Oct;288(4):839-44
references.pmid: 23553196
references.citation: Biometrics. 2012 Dec;68(4):1278-84
references.pmid: 22551393
references.citation: Cancer Res. 2010 Oct 1;70(19):7710-22
references.pmid: 20841469
references.citation: PLoS One. 2014 May 28;9(5):e98582
references.pmid: 24870408
references.citation: J Biol Chem. 2002 Aug 30;277(35):32389-99
references.pmid: 12105213
references.citation: CA Cancer J Clin. 2014 Mar-Apr;64(2):104-17
references.pmid: 24639052
references.citation: Stat Med. 2012 Dec 20;31(29):3805-20
references.pmid: 22763950
references.citation: Bioinformatics. 2005 Sep 15;21(18):3672-3
references.pmid: 15955784
references.citation: Br J Cancer. 1998 Apr;77(7):1164-8
references.pmid: 9569056
references.citation: World J Gastroenterol. 2013;19(14):2197-207
references.pmid: 23599646
references.citation: Oncol Rep. 2004 Jun;11(6):1193-200
references.pmid: 15138555
references.citation: Oncol Rep. 2003 Sep-Oct;10(5):1257-63
references.pmid: 12883690
references.citation: Surg Today. 1999;29(2):116-20
references.pmid: 10030735
references.citation: J Surg Oncol. 2001 Jan;76(1):58-62
references.pmid: 11223826
references.citation: Clin Cancer Res. 2009 Dec 15;15(24):7642-7651
references.pmid: 19996206
references.citation: Eur J Surg Oncol. 2001 Mar;27(2):170-4
references.pmid: 11289754
references.citation: Dis Colon Rectum. 1995 Jun;38(6):651-4
references.pmid: 7774480
references.citation: Arq Gastroenterol. 2010 Oct-Dec;47(4):361-7
references.pmid: 21225146
references.citation: CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
references.pmid: 20610543
references.citation: Biochem J. 2002 Sep 15;366(Pt 3):807-16
references.pmid: 12010125
references.citation: Mol Cell Biochem. 2009 Sep;329(1-2):51-62
references.pmid: 19387795
references.citation: Int J Cancer. 2011 Apr 15;128(8):1935-45
references.pmid: 20560137
references.citation: J Clin Pathol. 2004 Dec;57(12):1312-8
references.pmid: 15563674
references.citation: Zhonghua Bing Li Xue Za Zhi. 2003 Apr;32(2):115-9
references.pmid: 12839671
references.citation: Asian Pac J Cancer Prev. 2013;14(3):1995-8
references.pmid: 23679306
references.citation: Exp Mol Med. 2012 Mar 31;44(3):214-24
references.pmid: 22192927
references.citation: JAMA. 2006 Feb 8;295(6):676-80
references.pmid: 16467236
references.citation: Am J Surg Pathol. 2009 Apr;33(4):572-82
references.pmid: 19047896
references.citation: J Biol Chem. 2007 Apr 20;282(16):12075-96
references.pmid: 17314099
references.citation: Pathol Oncol Res. 2006;12(1):21-7
references.pmid: 16554912
references.citation: J Natl Cancer Inst. 2012 Oct 3;104(19):1433-57
references.pmid: 23019048
references.citation: Acta Pharmacol Sin. 2011 Mar;32(3):375-84
references.pmid: 21278784
references.citation: Med Pediatr Oncol. 2001 Jan;36(1):93-6
references.pmid: 11464913
references.citation: Zhonghua Bing Li Xue Za Zhi. 1995 Dec;24(6):356-8
references.pmid: 8732091
references.citation: J Bioenerg Biomembr. 2006 Aug;38(3-4):151-61
references.pmid: 16944301